Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed, indicating the record has been updated.SummaryDifference0.1%

- Check36 days agoChange DetectedThe history now shows a new revision tag 'Revision: v3.6.6' added to the history, replacing the previous 'Revision: v3.6.5'. This indicates an update to the study record's revision history.SummaryDifference0.1%

- Check57 days agoChange DetectedA new Revision: v3.6.5 entry was added to the record history, indicating the study record history has been updated. The update is metadata about versioning rather than a modification to the study data.SummaryDifference12%

- Check72 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, and the previous revision v3.6.3 was removed. This update reflects a new version stamp for the record.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision label in the history view updated from v3.6.2 to v3.6.3. This indicates a new site update for the record history interface without changing the underlying study data or how the page functions.SummaryDifference0.1%

- Check100 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history, and the previous v3.6.0 entry was removed. This reflects an update to the page’s revision metadata rather than substantive study information.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.